Postoperative hormone replacement therapy for epithelial ovarian cancer patients: A systematic review and meta-analysis

被引:51
|
作者
Li, Dong [1 ,2 ]
Ding, Cheng-yi [3 ]
Qiu, Li-hua [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200127, Peoples R China
[2] Shanghai Key Lab Gynecol Oncol, Shanghai 200127, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
关键词
Hormone replacement therapy; Epithelial ovarian cancer; Overall survival; Recurrence; Meta-analysis; RISK; CARCINOMA; DIAGNOSIS; PROGNOSIS; SURVIVORS; SURGERY; QUALITY; SAFETY;
D O I
10.1016/j.ygyno.2015.07.109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Hormone replacement therapy (HRT) has been proven highly effective for menopausal symptoms caused by radical surgery. However, the impact of postoperative HRT on the clinical outcomes of patients previously treated for epithelial ovarian cancer (EOC) remains unclear. Objective. To determine whether postoperative HRT use has any positive or negative impacts on prognosis and recurrence among EOC survivors. Methods. Studies that provided an assessment of postoperative HRT use and prognosis or recurrence in EOC patients were included for analysis. Two reviewers independently evaluated the eligibility of identified studies and abstracted the data. A fixed effects model was used to pool study-specific estimates of hazard ratios (HRs) or relative risks (RRs) with 95% confidence intervals (Cls). Results. Two randomized controlled trials (Ras) and four cohort studies included 419 EOC survivors who used HRT and 1029 non-users. The aggregated HR of overall survival (OS) suggested that HRT use after surgery for EOC had a favorable impact on OS (HR = 0.69, 95% CI: 0.61-0.79), but when these studies were categorized into cohort study and RCT subgroups, not all of them demonstrated positive results (HR = 0.63,95% CI: 0.49-0.81 and HR = 1.03, 95% Cl: 0.58-1.83, respectively). The meta-analysis of EOC recurrence of three available studies demonstrated that postoperative HRT use was not associated with an increased risk of recurrence in EOC survivors (RR = 0.83,95% Cl: 0.64-1.07). This pattern also emerged in the subgroup analysis for the stage and type of HRT. Conclusions. In EOC patients, postoperative HRT does not have a negative effect on overall survival and tumor recurrence. However, well-designed and large-scale Ras are needed to verify this relationship in the future. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 50 条
  • [31] Prognostic Role of Hormone Receptors in Ovarian Cancer A Systematic Review and Meta-Analysis
    Zhao, Dong
    Zhang, Fengmei
    Zhang, Wei
    He, Jing
    Zhao, Yulan
    Sun, Jing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (01) : 25 - 33
  • [32] Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis
    Shah, NR
    Borenstein, J
    Dubois, RW
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 668 - 678
  • [33] Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis
    Xu, Yu
    Jia, Ya
    Zhang, Qianwen
    Du, Yi
    He, Yuedong
    Zheng, Ai
    GYNECOLOGIC ONCOLOGY, 2021, 160 (02) : 610 - 618
  • [34] The Role of BRCA Status on the Prognosis of Patients with Epithelial Ovarian Cancer: A Systematic Review of the Literature with a Meta-Analysis
    Sun, Chaoyang
    Li, Na
    Ding, Dong
    Weng, Danhui
    Meng, Li
    Chen, Gang
    Ma, Ding
    PLOS ONE, 2014, 9 (05):
  • [35] Effect of pharmacogenomic polymorphism on hormone therapy for breast cancer patients: systematic review and meta-analysis
    Kuo, C. Y.
    Chou, Y. Z.
    Ho, C. S.
    Cheng, K. C.
    Mafruhah, O. R.
    Su, M. X.
    Liu, L. C.
    Lin, H. W.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 102 - 102
  • [36] Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis
    Boue, Antoine
    Joly, Florence
    Lequesne, Justine
    Lange, Marie
    CANCER, 2024, 130 (12) : 2120 - 2138
  • [37] Hormone replacement therapy and risk of epithelial ovarian cancer
    D M Purdie
    C J Bain
    V Siskind
    P Russell
    N F Hacker
    B G Ward
    M A Quinn
    A C Green
    British Journal of Cancer, 1999, 81 : 559 - 563
  • [38] Hormone replacement therapy and risk of epithelial ovarian cancer
    Purdie, DM
    Bain, CJ
    Siskind, V
    Russell, P
    Hacker, NF
    Ward, BG
    Quinn, MA
    Green, AC
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 559 - 563
  • [39] The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis
    Wen, Hui
    Lin, Xuefeng
    Sun, Daqiang
    JOURNAL OF THORACIC DISEASE, 2022, 14 (02) : 381 - +
  • [40] The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis
    Cui, Y.
    Zong, H.
    Yan, H.
    Zhang, Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (02) : 132 - 143